Using diamagnetic therapy to treat pain and inflammation
Low Frequency High Intensity- Pulsed Magnetic Fields (LF-HI-PEMF) in Pain and Inlfammation
This study is testing if a new type of magnetic therapy can help people with pain and inflammation feel better over the course of a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University of Catanzaro Academic / other |
| Locations | 2 sites (Catanzaro, Italia and 1 other locations) |
| Trial ID | NCT06844552 on ClinicalTrials.gov |
What this trial studies
This clinical study investigates the effects of Low Frequency High Intensity-Pulsed Magnetic Fields (LF-HI-PEMF) on patients suffering from pain and inflammation. Patients are enrolled and monitored over a year, with assessments at baseline and follow-up intervals of 30 days, 60 days, 90 days, and 360 days. The study aims to evaluate the efficacy of this therapy by measuring changes in pain levels using the Visual Analogue Scale (VAS). Additionally, questionnaires are administered to gather clinical and laboratory data throughout the study.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 75 with significant pain or inflammation who have not benefited from systemic treatments.
Not a fit: Patients with active malignancies, infections, or neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could provide a non-invasive treatment option for patients with chronic pain and inflammation who have not responded to traditional medications.
How similar studies have performed: While the specific approach of LF-HI-PEMF is less common, similar therapies have shown promise in managing pain and inflammation in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of both sexes between 18 and 75 years old 2. Patients with pain and or inflammation (e.g. osteoarthritis, trauma, prostatitis) 3. Patients with VAS (Visual Analogue Scale) intensities higher than 5/10 who did not respond to systemic medication therapy. 4. Patients who can comprehend the study's objectives and adhere to the clinical instructions, return for follow-up, and complete the evaluation questionnaires. 5. Patients able to provide their written informed consent to participate to the study and to use their data anonymously for scientific purposes Exclusion Criteria: 1. presence of active malignancy of any type or history of malignancy 2. Local or systemic infection. 3. Uncooperative patient or suffering from neurological disorders, therefore unable to follow the clinical instructions or unable to provide informed consent for participation in the study or who have not provided written consent. 4. Any case not described in the inclusion criteria. Patients with contraindication to magnetic resonance imaging
Where this trial is running
Catanzaro, Italia and 1 other locations
- AOU Dulbecco Catanzaro — Catanzaro, Italia, Italy (Recruiting)
- Luca Gallelli — Catanzaro, Italy (Recruiting)
Study contacts
- Study coordinator: Luca Gallelli, MD
- Email: gallelli@unicz.it
- Phone: 0961712322
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.